TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,730,975 | -7.6% | 8,089,315 | 0.0% | 0.10% | -9.5% |
| Q2 2023 | $24,591,518 | +61.7% | 8,089,315 | 0.0% | 0.10% | +69.4% |
| Q1 2023 | $15,207,912 | +84.3% | 8,089,315 | 0.0% | 0.06% | +100.0% |
| Q4 2022 | $8,251,101 | +38683.1% | 8,089,315 | 0.0% | 0.03% | -60.8% |
| Q3 2022 | $21,275 | -99.9% | 8,089,315 | 0.0% | 0.08% | -34.7% |
| Q2 2022 | $36,483,000 | -54.2% | 8,089,315 | 0.0% | 0.12% | -40.1% |
| Q1 2022 | $79,599,000 | -35.6% | 8,089,315 | 0.0% | 0.20% | -34.8% |
| Q4 2021 | $123,686,000 | +12.8% | 8,089,315 | 0.0% | 0.31% | +26.5% |
| Q3 2021 | $109,691,000 | -7.7% | 8,089,315 | 0.0% | 0.24% | -8.6% |
| Q2 2021 | $118,832,000 | – | 8,089,315 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $28,857,000 | 27.11% |
| Aisling Capital Management LP | 682,923 | $6,720,000 | 3.63% |
| Cormorant Asset Management, LP | 1,174,723 | $11,559,000 | 0.89% |
| Artal Group S.A. | 2,064,262 | $20,312,000 | 0.85% |
| SECTORAL ASSET MANAGEMENT INC | 228,624 | $2,250,000 | 0.40% |
| Logos Global Management LP | 306,236 | $3,013,000 | 0.39% |
| Eventide Asset Management | 1,561,092 | $15,361,000 | 0.24% |
| Blackstone Inc. | 8,089,315 | $79,599,000 | 0.20% |
| HHLR ADVISORS, LTD. | 698,797 | $6,876,000 | 0.14% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $32,370,000 | 0.13% |